Objective: To present an up-to-date and critical review regarding food allergies, focusing mainly on treatment and prevention.
Introduction
The prevalence of allergic diseases has increased dramatically in children and young adults over the past few decades, and food allergies (FA) constitute a part of this increase. 1, 2 Food allergies have become a major health concern worldwide over the past two decades and are associated with a significant negative impact on the quality of life. 3 Risks to well being increase as the foods consumed in a population are increasingly likely to be processed and complex, with inadequate labeling. 4 FA are much more common in the pediatric age group than in adults and has significant medical, financial and social impact on young children and their families. 2, 5 Surveys suggest that between 5 and 25% of adults believe that they or their children are affected. 6 The true prevalence of FA in children remains unclear because various studies apply different inclusion criteria, diagnostic definitions and methods. There is a need for standardization of definitions, diagnostic procedures, test methods and careful categorization of cases for a more homogeneous description of patients and comparison of clinical outcomes. Comparative data need to be interpreted with caution, and there is a necessity to differentiate between diagnoses made by self-reporting, by measurements of sensitization using IgE antibody-based criteria and by carefully conducted clinical challenges. 5 Overestimation of FA by patients and their families is well documented. 2, 5, 6 Adult patients often misjudge their own FA because of confusion between true allergy as opposed to food intolerances. 2, 7 Similarly, parents commonly overestimate FA in their children. In a cohort of 520 consecutive newborn babies investigated over the first 3 years of life, only 6% of children reacted to suspected foods in a double-blind placebo-controlled oral food challenge. In contrast, parents believed their child to be food-allergic in 28% of cases. 8 Recent studies have shown that as much as one fourth of U.S. households report the perception of a family member having a food allergy, 9 while in Spain about 1/6 of parents attribute minor symptoms or changes in their infant's behavior to cow's milk allergy. 10 Much of the controversy surrounding this subject has stemmed from loosely labeling any untoward reaction to food as an allergy, when in fact many clinical responses are food intolerance reactions, rather than FA. 2 This review updates published information about FA, focusing mainly on its treatment and prevention.
Terminology
FA, defined as an adverse immune response to food allergens, affects as much as 6-8% of young children and 3-4% of adults. 6, 8, 11 Other non-immune-mediated adverse reactions to food can be caused by a variety of mechanisms,
including digestive enzyme deficiencies (as in the case of lactose intolerance) or toxins (staphylococcal food poisoning), as well as psychological aversions. However, food hypersensitivity (often used synonymously with FA) may be defined as a reproducible adverse clinical reaction following the ingestion of dietary protein allergens, mediated by an abnormal immune response. 1, 11, 12 The World Allergy Organization proposed a new nomenclature for the definitions of allergy in 2003. 13, 14 Hypersensitivity should be used to describe reproducible symptoms or signs initiated by exposure to a definite stimulus at a dose tolerated by normal persons. In contrast, intolerance was suggested to describe an abnormal physiological response to an agent which is non-immunemediated. The term atopy was suggested as referring to a characteristic that makes one susceptible to develop various allergies, while allergy is a hypersensitivity reaction initiated by specific immunological mechanisms. Food allergy refers to a group of disorders with an abnormal or exaggerated immunological response to specific food proteins that may be IgE or non-IgE-mediated. When other mechanisms can be proven, the term non-allergic hypersensitivity is recommended.
13,14

Pathogenesis
Although significant advances have been made in our understanding of the mucosal immune system, the precise pathogenesis of most food hypersensitivity reactions remain incompletely understood. Several factors clearly play important roles, including genetics, host's intestinal flora, the timing, dosage, and frequency of exposure to various dietary allergens, as well as the allergenicity of various food proteins. 2, 15 Immaturity of the intestinal mucosal barrier has been suggested as one mechanism that may explain the higher incidence of food allergy in infants and children. 12 However, despite the fact that macromolecular uptake is increased in preterm infants, this is not necessarily associated with an increased incidence of food allergy. 2, 16 Abnormalities in the induction or maintenance of oral tolerance have been suggested to play a role in the development of food hypersensitivity reactions.
Experimental studies suggest a key role of the bacterial flora in the development of allergy and tolerance. 17 However, despite the explosion of information providing new insights into the mechanisms of oral tolerance in mice, relatively little is known about the ontogeny of oral tolerance mechanisms and the key roles of dendritic and T regulatory cells in humans. 18 The production of allergen- Although false positives are problematic in children with atopic dermatitis, false negative skin prick tests are 27 The use of assays for allergen-specific serum IgE is helpful in such circumstances. 24 Because of the low and variable predictive accuracy and lack of standardized approach to testing, the patch test is also not currently indicated for routine use. 22 Other unapproved and useless tests include provocationneutralization cytotoxic tests, IgG antibody assays to specific foods, and hair analyses. The measurement of inflammatory markers in blood and stool that accurately predict reaction to foods would be formulas are completely allergen-free, and rare severe reactions to eHPF have been described. 30 In severe cases resistant to eHPF therapy or in patients with multiple food allergies, amino acid-based formulas are necessary.
The use of soy protein-based formulas for cow's milk allergy is somewhat controversial. In general, it is not advisable to introduce a new food, such as soy, to patients with an actively inflamed and damaged, hyperpermeable mucosal barrier for at least 1 month, so as not to "sensitize" them to another potent allergen. Moreover, concomitant soy and cow's milk protein allergies may be present in an individual despite the fact that no "cross reactivity" exists.
The prevalence of concomitant soy intolerance in infants with cow's milk allergy ranges widely (0-60%) in different studies, depending upon the criteria employed (whether placebo-controlled challenges were performed or not). 2 In a study that employed placebo-controlled challenges, 14% of infants with type I (IgE+) cow's milk allergy were documented to have soy allergy. 35 A higher probability has been observed in non-IgE-mediated enterocolitis. 36 A recent prospective, randomized trial of 170 infants with documented cow's milk allergy addressed these issues. 37 Infants were assigned to a standard soy protein, or a cow's milk-based eHPF. The outcome was that 10% reacted to soy, whereas only 2.2% reacted to the hydrolysate formula. The Microbial agents may also have an important effect on atopic sensitization and induction of tolerance. 22 The use of probiotic therapy to prevent allergic disease has been investigated in neonates, demonstrating a long-term reduction in atopic dermatitis. 47 The normal interaction between the newborn's mucosal immune system and microbes is thought to be compromised in industrialized nations, particularly in bottle-fed infants, resulting in a reduction of bifidobacteria and an increase in clostridial species in the intestinal flora. 47 Infants with milk allergy and atopic eczema have exhibited milder symptoms and fewer markers of intestinal inflammation when their cow's milk formula was fortified with lactobacilli, supporting a favorable effect of adding probiotics to infant formulas. 22 At the present time food allergen avoidance is the only way to treat and prevent FA. In the near future, food manipulation with molecular and immunological engineering will hopefully deliver more promising and enduring strategies in the prevention of allergic diseases.
Avoidance can be presently instituted at any of the three stages of allergy prevention, termed primary, secondary or tertiary prevention. Primary prevention attempts to decrease the likelihood of the initial sensitization and onset of symptoms in at-risk, as yet unsensitized individuals.
Primary prevention blocks immunologic sensitization to foods, particularly due to IgE antibodies. It has been suggested that a critical period exists prior to or early after birth during which the genetically programmed, atopy-prone child may be at increased risk of becoming sensitized to the encountered allergens. 22 The challenge is to promptly identify at-risk infants and to institute preventive measures that are cost-effective, realistic, and acceptable. 2 Secondary prevention is directed towards already sensitized individuals, in order to suppress disease expression after sensitization. Tertiary prevention tries to limit symptoms and additional problems in subjects already suffering from chronic allergy. 22 Tertiary prevention is the stage of treatment in which there is an attempt to avoid recurrence of symptoms and susceptibility to other potential antigenic proteins.
Primary allergy prevention has focused on two major objectives: the prevention of sensitization to milk and other food allergens, and the prevention of early atopic dermatitis, a disease marker highly predictive of the so called "allergic career". 48 
Intervention strategy during pregnancy
Although some studies showed a beneficial effect of maternal adherence to a milk-free diet during late pregnancy and lactation, it is unclear whether the benefits were due to maternal dietary restrictions, to lactation, or both. Furthermore, other studies failed to show a benefit of a restricted diet during pregnancy, and this was confirmed by a meta-analysis. 50 In addition to these negative findings,
Food allergy -Ferreira CT & Seidman E maternal weight gain was compromised by the restriction of cow's milk and eggs, considered key foods during pregnancy. 43 Currently, the consensus is that there is no scientific basis for recommending a restricted diet during late pregnancy. 15, 43, 49 Intervention strategy during breastfeeding for the newborn It has long been held that breastfeeding affords passive immunity against infections, and may also actively stimulate the infant's immune system, providing multiple Use of a hypoallergenic formula -eHF or amino acid based formula -lactose-free and with medium chain triglycerides until normal absorptive function returns
The formula must be selected according to each patient's condition when there is a significant intestinal injury AAP = American Academy of Pediatrics; CM = cow's milk; CMA = cow's milk allergy; eHF = extensive hydrolyzed formulas; ESPGHAN = European Society for Pediatric Gastroenterology, Hepatology and Nutrition; pHF = partially hydrolyzed formulas. although not exclusively, to at least 12 months of age. 43, 49 The Brazilian Health Ministry recommends continuing breastfeeding until 2 years of age, although this is more for socioeconomic reasons than for allergy prevention. 54 These recommendations are the same for all newborns, whether at risk for atopy or not. The safety of exclusive breastfeeding for 6 months has already been demonstrated by a meta-analysis. 55 This recommendation reduces infant illnesses at the community level and can potentially reduce the overall cost of health services.
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Intervention strategy during breastfeeding for the mother
In the general, not-at risk population, the prevalence of FA in exclusively breastfed infants ranges from 0.04% to 0.5%. 43, 56 Beta-lactoglobulin, casein, gammaglobulin, ovalbumin, gliadin and peanut antigens have been detected in small quantities in breastmilk 1 to 6 hours after the consumption of these foods, irrespective of maternal status of atopy. The concentrations of food allergens in breastmilk are thus theoretically sufficient to trigger reactions in allergic infants. The molecular size of these food antigens in maternal milk is similar to their respective allergens, thus confirming, although not proving their potential for sensitization. 43, 57 Some studies have therefore evaluated the utility of maternal food allergen avoidance diets during lactation for preventing atopic disease in high-risk infants. [58] [59] [60] Two prospective controlled studies evaluated whether maternal diet for the first 3 months of lactation and avoidance of soy and peanuts for the entire lactation period affected atopy in high-risk infants placed on a relatively hypoallergenic dietary regimen during infancy. These studies noted significant reductions of atopic eczema in the maternal diet groups by ages 3, 6 and 18 months. However, at 10 years of age the rates of allergies were the same between the children in both groups. 59, 60 A meta-analysis of these studies concluded that a food allergen avoidance diet of the mothers during lactation may transiently reduce the development of eczema in early childhood. 50 The authors also noted that methodological limitations of the reported studies suggest caution before implementing the findings.
Moreover, other studies conflict with the above findings. For this reason advisory committees are more prudent on this point and suggest implementing a restrictive maternal diet during lactation only after evaluation of each family's atopic risk and individual circumstances. 43 The AAP 49 recommends avoidance of peanuts because it is not an essential food and peanut allergy is very common in the USA. In mothers following dietary restrictions, the AAP 49 suggests supplemental calcium and a multivitamin preparation.
Intervention strategy in formula-fed infants
It has been shown that exposure to even a small amount of cow's milk formula during the first days after birth can increase the likelihood of cow's milk protein allergy. 56 Both hydrolyzed formula and breastmilk have been reported to protect against cow's milk allergy, compared to the use of routine, cow's milk-based infant formula. 61 excluded. At 12 months, the incidence of allergic manifestations was significantly lower with the caseinbased eHPF than with the conventional formula (9 vs. 16%).
The pHPF was almost as effective (11%), whereas the whey-based eHPF did not confer a benefit (14%). The authors suggested that the different preventive benefits between whey-and casein-based extensively-hydrolyzed formulas might be explained by different hydrolyzation processing using different enzymes, rather than by the degree of hydrolyzation or the protein source. They speculated that the hydrolyzation process might influence the remaining epitopes and consequently, the residual antigenicity of a particular hydrolysate. 1 As anticipated, the most frequent allergic manifestation observed during the first year of this study was atopic dermatitis. Both the pHPF and the casein-based eHPF reduced the incidence of atopic dermatitis (9 and 7%) compared to the conventional and whey-based eHPF (15 and 13%, respectively; p < 0.05).
Taken together, the findings in this study suggest that the degree of hydrolysis is less critical than the tolerogenic properties of the specific formula. 1 The family history was found to be a key determinant of outcome in this study. The benefits of the pHPF and casein-based eHPF were far less impressive if the family history was positive for atopic dermatitis. Atopic dermatitis in first degree family members was found to be a stronger risk factor for the development of allergic manifestations during infancy than the history of any other allergic disease in two members of the family. The final issue is whether there is evidence that an allergen-reduced diet is beneficial for infants in the general population, without particular risk factors. This issue is highly relevant, in view of the rapidly increasing incidence of atopic diseases in many countries. The ZUFF study 46, 67 addressed this issue by comparing a treatment (breastfed and/or pHPF, no regular infant formula or solids for 4 months) with a normally fed control group . Although growth was similar in all groups, skin problems were reduced in the treatment compared to freely fed control infants at 2 years (7 vs. 15%, p < 0.0001). Feeding a pHPF to partially or non-breastfed infants resulted in the same overall health benefits as exclusive breastfeeding, in contrast to routine formula. 46, 67 Is there a place for soy formulas in primary prevention?
Soy-based formulas have been used to treat infants with allergy or food intolerance, but according to existing studies there is insufficient evidence to recommend soy formula feeding for primary prevention of FA. Soy protein is immunogenic and allergenic. 42 A low prevalence of soy allergy has been found by double-blind, placebo-controlled food challenge both in children with food allergy and in infants of atopic parents fed soy formula from birth or early Food allergy -Ferreira CT & Seidman E in life. [68] [69] [70] Randomized prospective studies of soy versus cow's milk formula feeding in infants, generally from atopic families, have not shown any preventive effect of soy on FA or atopic dermatitis. 42 Both the AAP 49 and ESPGHAN 15 committees agree that there is insufficient evidence to recommend soy formula for primary food allergy prevention (Table 3) . According to AAP, 49 there may be a place for soy formula feeding in the secondary prevention of IgE-mediated food allergy.
A recent Cochrane Library review assessed whether feeding infants without clinical evidence of food allergy or intolerance an adapted soy formula compared to human milk, cow's milk formula or a hydrolyzed protein formula prevents allergy or food intolerance. 71 They found only five eligible studies, all enrolling infants at high risk of allergy on the basis of a family history of allergy in a first degree relative. No eligible study enrolled infants fed human milk.
Comparing soy to cow's milk formula one study with unclear allocation criteria and 19,5% losses to follow-up reported a reduction in the cumulative incidence of childhood allergy, asthma and allergic rhinitis. It was concluded that soy formula feeding should not be recommended for the prevention of allergy or food intolerance in infants at high risk. 71 
